375 related articles for article (PubMed ID: 23363701)
1. Immunotherapy with commercial venoms is efficacious for anaphylactic reactions to Vespa orientalis stings.
Goldberg A; Shefler I; Panasoff J; Paitan Y; Confino-Cohen R
Int Arch Allergy Immunol; 2013; 161(2):174-80. PubMed ID: 23363701
[TBL] [Abstract][Full Text] [Related]
2. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
Goldberg A; Confino-Cohen R; Mekori YA
Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
[TBL] [Abstract][Full Text] [Related]
3. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
6. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting.
Kosnik M; Korosec P; Silar M; Music E; Erzen R
Croat Med J; 2002 Feb; 43(1):25-7. PubMed ID: 11828554
[TBL] [Abstract][Full Text] [Related]
7. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
Haeberli G; Brönnimann M; Hunziker T; Müller U
Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
Kochuyt AM; Van Hoeyveld EM; Stevens EA
Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
[TBL] [Abstract][Full Text] [Related]
9. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
10. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
Gawlik R; Glück J; Jawor B; Rogala B
Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
[TBL] [Abstract][Full Text] [Related]
11. Insect sting allergy with negative venom skin test responses.
Golden DB; Kagey-Sobotka A; Norman PS; Hamilton RG; Lichtenstein LM
J Allergy Clin Immunol; 2001 May; 107(5):897-901. PubMed ID: 11344359
[TBL] [Abstract][Full Text] [Related]
12. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
13. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life.
Koschel DS; Schmies M; Weber CN; Höffken G; Balck F
J Investig Allergol Clin Immunol; 2014; 24(4):226-30. PubMed ID: 25219104
[TBL] [Abstract][Full Text] [Related]
14. Discontinuing venom immunotherapy: extended observations.
Golden DB; Kwiterovich KA; Kagey-Sobotka A; Lichtenstein LM
J Allergy Clin Immunol; 1998 Mar; 101(3):298-305. PubMed ID: 9525443
[TBL] [Abstract][Full Text] [Related]
15. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
16. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
17. Reassessing the role of hyaluronidase in yellow jacket venom allergy.
Jin C; Focke M; Léonard R; Jarisch R; Altmann F; Hemmer W
J Allergy Clin Immunol; 2010 Jan; 125(1):184-90.e1. PubMed ID: 19910026
[TBL] [Abstract][Full Text] [Related]
18. [The wasp/mosquito syndrome].
Sabbah A; Hassoun S; Drouet M; Lauret MG; Doucet M
Allerg Immunol (Paris); 1999 Jun; 31(6):175-84. PubMed ID: 10443298
[TBL] [Abstract][Full Text] [Related]
19. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
20. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
